Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,746.50
Bid: 1,742.50
Ask: 1,743.00
Change: 6.50 (0.37%)
Spread: 0.50 (0.029%)
Open: 1,730.00
High: 1,746.50
Low: 1,729.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Downgrades Rolls-Royce To Sell

Mon, 16th Jun 2014 09:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BARCLAYS RAISES RSA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 538 (102) PENCE
----------
SOCGEN CUTS ROLLS-ROYCE TO 'SELL' ('HOLD') - TARGET 950 (1070) PENCE
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 2100 (2075) PENCE - 'BUY'
----------
HSBC RAISES BG GROUP PRICE TARGET TO 1425 (1260) PENCE - 'OVERWEIGHT'
----------
EXANE RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4500) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS BHP BILLITON PRICE TARGET TO 1850 (2000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS RIO TINTO PRICE TARGET TO 3800 (4070) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES WEIR GROUP PRICE TARGET TO 2540 (2390) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
GOLDMAN RAISES HISCOX PRICE TARGET TO 607 (606,74) PENCE - 'SELL'
----------
HSBC RAISES PARAGON GROUP PRICE TARGET TO 380 (335) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES DEBENHAMS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TP 73 (64) PENCE
----------
CREDIT SUISSE CUTS FENNER PRICE TARGET TO 405 (490) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES HALMA PRICE TARGET TO 665 (620) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES LAIRD PRICE TARGET TO 270 (215) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE RAISES MORGAN ADVANCED MATERIALS TP TO 310 (270) PENCE - 'UNDERPEFORM'
----------
CREDIT SUISSE RAISES ROTORK PRICE TARGET TO 2600 (2450) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SENIOR PLC PRICE TARGET TO 335 (315) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
NUMIS CUTS CRODA PRICE TARGET TO 2554 (2575) PENCE - 'HOLD'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 119 (122) PENCE - 'NEUTRAL'
----------
LIBERUM INITIATES NCC GROUP WITH 'BUY' - TARGET 220 PENCE
----------
Investec Cuts Majestic Wine To Add from Buy, PT 460p
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.